Early outcomes indicate that anterior optic capture is a safe, accurate procedure in eyes with multifocal IOLs and a mild hyperopic residual refractive error postoperatively.
Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation. Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near (UCNVA) and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy. Results: Three months after 25-gauge TSV the mean visual acuities were: UCDVA, 0,10 ± 0,14; BCDVA, 0,02 ± 0,08; UCNVA, 0,00 ± 0,0; SE, +0,16 ± 0,34. Thirteen eyes (92.9%) had a UCDVA of 0.5 (20/40) or better, and 11 (78.5%) achieved a UCDVA of 0.8 (20/25) or better. Ten (90.9%) patients demonstrated satisfaction with surgery, and floaters have gone away in thirteen eyes (92.8%), while one patient expressed no satisfaction with her postoperative visual acuity because of the cystoid macular edema that occurred. Conclusion: 25-gauge TSV was a safe and accurate option for patients with multifocal lens and visual disturbing vitreous floaters providing subjective improvement of symptoms. Os autores não apresentam nenhum interesse financeiro no material apresentado Recebido para publicação em: 23
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.